| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal ID3793: Baloxavir marboxil for influenza prophylaxis in people aged 12 and over |
|
Medicine details |
|
| Medicine name | baloxavir marboxil (Xofluza®) |
| Formulation | 20 mg and 40 mg film-coated tablet20 mg and 40 mg film-coated tablet |
| Reference number | 4409 |
| Indication | Post-exposure prophylaxis of influenza in individuals aged 12 years and above |
| Company | Roche Products Ltd |
| BNF chapter | Infections |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 13/05/2021 |
| NICE guidance | ID3793: Baloxavir marboxil for influenza prophylaxis in people aged 12 and over |